Advanced Filters
noise

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,133 clinical trials

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.

18 years of age All Phase N/A
L Lauren Enten, B.S.A.

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

The purpose of the study is to identify brain biomarkers and characteristics that predict individual responses to treatment of major depression with the antidepressant drug sertraline (tradename Zoloft), a common selective serotonin reuptake inhibitor (SSRI) antidepressant. Our central hypothesis is that brain activity and connections jointly measured with functional magnetic …

18 - 65 years of age All Phase 4
K Kymberly Young, PhD

Amygdala Neurofeedback for Depression - Large Scale Clinical Trial

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder

18 - 55 years of age All Phase N/A
N Nicole Stinson, BSc

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

This is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).

18 - 65 years of age All Phase 4
S Simona Palm, PhD

Evaluation of a Male-specific Psychotherapeutic Program for Major Depressive Disorders

This project aims to evaluate a male-specific psychotherapeutic program (MSPP) for MDD based on cognitive behavioral therapy (CBT). The primary goal is to test the superiority of the MSPP. This will be conducted in two groups of depressed men, namely eudonadal depressed men and hypogonadal depressed men receiving testosterone treatment …

25 - 50 years of age Male Phase N/A
U Uyen Le, BSN, RN

Positioning of Esketamine Treatment in the Real-world Management of Depression

The goal of this naturalistic, open label, single arm intervention study is to investigate the effects of Esketamine in treating depression.The main aims to answer are: to investigate whether Esketamine is effective when added to ongoing antidepressant treatment to identify patient characteristics that will determine a therapeutic response to Esketamine …

18 - 65 years of age All Phase 4
D Daphne Voineskos, MD, PhD, FRCPC

E-field Guided iTBS for Treatment Resistant Depression

The purpose of this study is to establish how personalization of repetitive transcranial magnetic stimulation (rTMS) can change markers of brain activity and improve treatment response. To do this, all participants will receive the same active form of treatments, but some of the participants in this study will receive intermittent …

18 - 65 years of age All Phase N/A
M Michael Treadway, PhD

Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine

The main purpose of this study is to investigate the effects of ketamine on decision-making and emotion processing in a sample of individuals diagnosed with Major Depressive Disorder (MDD).

18 - 65 years of age All Phase 0
H Huang Manli

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway

Major depressive disorder(MDD) is a complex and heterogeneous mental disorder. Repeated transcranial magnetic stimulation (rTMS), as a non-invasive neuroregulatory technique, has shown a promising function in the treatment of depression. Theta-burst transcranial magnetic stimulation (TBS) model significantly shortened the duration of physical therapy treatment, and iTBS under the accelerated model …

12 - 45 years of age All Phase N/A
C Claire Anderson, BA

Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

This study looks at the role of the Nociceptin/Orphanin FQ receptor system in the brain of individuals with current or past major depressive disorder (MDD). It also examines how individuals with a history of depression make certain decisions and which brain regions are involved in such decisions. Information collected through …

18 - 45 years of age All Phase N/A

Simplify language using AI